April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 14, 2025 C-Path Honors Memory, Legacy of Beloved CP-RND Member and ALS Patient Advocate Layne Oliff Critical Path Institute (C-Path) mourns the loss of one of its ALS community members, Layne Oliff. Layne, who passed on Friday, Ap
April 9, 2025-April 10, 2025 2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
April 11, 2025 2025 Clinical Outcome Assessment Program Annual Meeting Recap On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
March 10, 2025 C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...
February 19, 2025 C-Path’s eCOA Consortium Welcomes Veeva Systems and VPG Health as Newest Partners C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...
February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.